IL37 and head and neck squamous cell carcinoma: Interestingly, small molecule inhibition of TGF-ß receptors coupled with IL23 treatment resulted in significantly decreased head and neck squamous cell carcinoma progression in a mouse model, primarily through lack of tumoriogenesis27.